Tricuspid atresia cardiac catheterization

Tricuspid atresia Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Tricuspid Atresia from other Disorders
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Cardiac Catheterization
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Special Scenarios
Pregnancy
Case Studies
Case #1
Tricuspid atresia cardiac catheterization On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tricuspid atresia cardiac catheterization All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tricuspid atresia cardiac catheterization
CDC on Tricuspid atresia cardiac catheterization
Tricuspid atresia cardiac catheterization in the news
Blogs on Tricuspid atresia cardiac catheterization
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Tricuspid atresia cardiac catheterization

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Associate Editor-In-Chief: Keri Shafer, M.D. [2] Priyamvada Singh, MBBS [[3]]

Assistant Editor-In-Chief: Kristin Feeney, B.S. [[4]]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Cardiac Catheterization

ACC/AHA Guidelines - Recommendation for Catheterization before Fontan Procedure (DO NOT EDIT)

“

Class I In the evaluation of hemodynamics to assess the potential for definitive palliation of unoperated or shunt-palliated adults with univentricular hearts, catheterization is indicated to: Assess the nature of pulmonary artery obstruction, with potential to restore maximal continuous, effective, unimpeded systemic venous flow to the maximal number of pulmonary artery segments. (Level of Evidence: C) Assess and eliminate systemic-to-pulmonary vein collaterals. (Level of Evidence: C Assess and eliminate systemic-to-pulmonary artery connections. (Level of Evidence: C) For adults with systemic-to-pulmonary shunts, the potential for perioperative transcatheter shunt exclusion should be examined. (Level of Evidence: C)

”